Published in MBio on August 30, 2011
Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans. J Immunol (2012) 1.07
Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infect Immun (2011) 1.06
Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein. Infect Immun (2011) 1.06
Properdin in complement activation and tissue injury. Mol Immunol (2013) 0.95
Comparison of the potency of a variety of β-glucans to induce cytokine production in human whole blood. Innate Immun (2012) 0.89
Characterization and optimization of the glucan particle-based vaccine platform. Clin Vaccine Immunol (2013) 0.88
Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic. Clin Vaccine Immunol (2014) 0.87
The role of properdin in zymosan- and Escherichia coli-induced complement activation. J Immunol (2012) 0.87
Properdin: a tightly regulated critical inflammatory modulator. Immunol Rev (2016) 0.85
Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors. PLoS Pathog (2015) 0.81
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts. MBio (2015) 0.81
Integrin αXβ₂ is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections. J Immunol (2012) 0.80
Exploiting fungal cell wall components in vaccines. Semin Immunopathol (2014) 0.80
Aspergillus Cell Wall Chitin Induces Anti- and Proinflammatory Cytokines in Human PBMCs via the Fc-γ Receptor/Syk/PI3K Pathway. MBio (2016) 0.76
An overview of the synergy and crosstalk between pentraxins and collectins/ficolins: their functional relevance in complement activation. Exp Mol Med (2017) 0.75
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science (1954) 21.20
Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37
Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med (1975) 4.69
Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) (1984) 4.62
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 4.35
Infectious diseases associated with complement deficiencies. Clin Microbiol Rev (1991) 4.01
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol (2006) 3.62
Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature (2011) 3.32
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature (2009) 3.21
Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol (2010) 3.00
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med (1981) 2.88
The covalent-binding reaction of complement component C3. Biochem J (1981) 2.80
Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest (2011) 2.66
Dynamics of cell wall structure in Saccharomyces cerevisiae. FEMS Microbiol Rev (2002) 2.53
On the composition of zymosan. Science (1958) 2.35
Molecular organization of the cell wall of Candida albicans. Med Mycol (2001) 2.28
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol (2004) 2.00
The contribution of cell wall proteins to the organization of the yeast cell wall. Biochim Biophys Acta (1999) 1.94
Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med (2001) 1.91
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J Immunol (2001) 1.48
The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem (2005) 1.45
Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J Immunol (2008) 1.44
Complement deficiency states and meningococcal disease. Immunol Res (1993) 1.43
Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. Biochem J (1994) 1.42
Does properdin crosslink the cellular and the humoral immune response? Immunol Today (1999) 1.39
Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol (1997) 1.37
Activation of the complement system by pathogenic fungi. Clin Microbiol Rev (1996) 1.37
Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. J Immunol (1985) 1.33
Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood (2010) 1.31
Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect Immun (2009) 1.29
A refined method for the determination of Saccharomyces cerevisiae cell wall composition and beta-1,6-glucan fine structure. Anal Biochem (2002) 1.23
Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. MBio (2010) 1.22
Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol (2008) 1.20
Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood (2011) 1.18
Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery. Bioconjug Chem (2008) 1.17
Trafficking of B cell antigen in lymph nodes. Annu Rev Immunol (2011) 1.15
Analysis of the natural polymeric forms of human properdin and their functions in complement activation. J Immunol (1989) 1.15
Phagocytosis by human neutrophils is stimulated by a unique fungal cell wall component. Cell Host Microbe (2007) 1.15
An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol (2010) 1.07
Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement. Immunobiology (2010) 1.05
Defining targets for complement components C4b and C3b on the pathogenic neisseriae. Infect Immun (2007) 1.03
Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clin Cancer Res (2010) 0.99
Induced humoral immunity and vaccination against major human fungal pathogens. Curr Opin Microbiol (2002) 0.98
Properdin deficiency: molecular basis and disease association. Mol Immunol (2000) 0.96
A comparison of the pulmonary inflammatory potential of different components of yeast cell wall. J Toxicol Environ Health A (2007) 0.95
Pre-clinical safety evaluation of soluble glucan. Int J Immunopharmacol (1988) 0.92
A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy. J Exp Clin Cancer Res (2008) 0.91
Properdin. Methods Enzymol (1993) 0.90
Isolation and purification of C3 from human plasma. Curr Protoc Immunol (2001) 0.79
Dissimilar and similar functional properties of complement receptor-3 in microglia and macrophages in combating yeast pathogens by phagocytosis. Glia (2010) 0.79
Preparation of zymosan from yeast cell walls. Folia Microbiol (Praha) (1980) 0.76
Hidden killers: human fungal infections. Sci Transl Med (2012) 7.10
The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science (2005) 4.74
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol (2006) 3.62
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature (2009) 3.21
The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol (2004) 3.21
Tackling human fungal infections. Science (2012) 2.49
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun (2008) 2.29
The immune response to fungal infections. Br J Haematol (2005) 2.24
Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol (2003) 2.24
Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. J Infect Dis (2008) 2.00
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol (2004) 2.00
Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem (2002) 1.87
Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res (2003) 1.81
The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog (2010) 1.81
Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell (2007) 1.76
A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot Cell (2005) 1.76
Interactions between Neisseria meningitidis and the complement system. Trends Microbiol (2007) 1.72
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine (2012) 1.71
Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70
A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J Immunol (2011) 1.68
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A (2010) 1.66
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res (2006) 1.58
Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol (2002) 1.56
Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity. J Biol Chem (2003) 1.55
The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem (2003) 1.55
An interactional network of genes involved in chitin synthesis in Saccharomyces cerevisiae. BMC Genet (2005) 1.47
Chitin synthesis in Saccharomyces cerevisiae in response to supplementation of growth medium with glucosamine and cell wall stress. Eukaryot Cell (2003) 1.46
Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect Immun (2004) 1.42
Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun (2005) 1.41
A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe (2011) 1.41
PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot Cell (2008) 1.39
Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J Immunol (2008) 1.39
Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J Immunol (2005) 1.38
The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner. J Biol Chem (2003) 1.35
Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J Immunol (2006) 1.32
Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect Immun (2008) 1.32
The role of porins in neisserial pathogenesis and immunity. Trends Microbiol (2003) 1.30
Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun (2008) 1.30
Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect Immun (2009) 1.29
Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect Immun (2003) 1.27
Analysis of functions of the chitin deacetylase gene family in Tribolium castaneum. Insect Biochem Mol Biol (2009) 1.27
Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog (2006) 1.27
Characterization of two chitin synthase genes of the red flour beetle, Tribolium castaneum, and alternate exon usage in one of the genes during development. Insect Biochem Mol Biol (2004) 1.25
Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants. Infect Immun (2006) 1.25
Interactions of fungi with phagocytes. Curr Opin Microbiol (2002) 1.24
Implications of phase variation of a gene (pgtA) encoding a pilin galactosyl transferase in gonococcal pathogenesis. J Exp Med (2002) 1.22
Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. MBio (2010) 1.22
In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infect Immun (2006) 1.21
Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin. J Immunol (2007) 1.20
Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc Natl Acad Sci U S A (2005) 1.20
Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe (2011) 1.18
Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect Immun (2008) 1.17
Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery. Bioconjug Chem (2008) 1.17
The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein. PLoS Pathog (2012) 1.17
A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol (2005) 1.17
Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun (2005) 1.17
The ArcA regulon and oxidative stress resistance in Haemophilus influenzae. Mol Microbiol (2007) 1.14
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation. Brain (2014) 1.13
Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses. Infect Immun (2002) 1.12
The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. J Infect Dis (2013) 1.11
Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun (2006) 1.10
KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties. Eukaryot Cell (2004) 1.10
Role of complement in host defense against pneumococcal otitis media. Infect Immun (2009) 1.09
Innate sensing of chitin and chitosan. PLoS Pathog (2013) 1.09
Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans. J Immunol (2012) 1.07
An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol (2010) 1.07
Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun (2008) 1.07
Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infect Immun (2011) 1.06
lgtC expression modulates resistance to C4b deposition on an invasive nontypeable Haemophilus influenzae. J Immunol (2007) 1.06
Chitin synthases are required for survival, fecundity and egg hatch in the red flour beetle, Tribolium castaneum. Insect Biochem Mol Biol (2008) 1.06
Candida albicans CHT3 encodes the functional homolog of the Cts1 chitinase of Saccharomyces cerevisiae. Fungal Genet Biol (2005) 1.05
Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing. Infect Immun (2012) 1.05
The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci. J Immunol (2012) 1.04
Knickkopf protein protects and organizes chitin in the newly synthesized insect exoskeleton. Proc Natl Acad Sci U S A (2011) 1.04
Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin. Infect Immun (2009) 1.04
A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807. J Labelled Comp Radiopharm (2013) 1.03
Defining targets for complement components C4b and C3b on the pathogenic neisseriae. Infect Immun (2007) 1.03